Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2006 1
2016 2
2017 1
2018 2
2019 1
2021 1
2022 3
2023 1
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.
Weiß C, Becker LL, Friese J, Blaschek A, Hahn A, Illsinger S, Schwartz O, Bernert G, Hagen MV, Husain RA, Goldhahn K, Kirschner J, Pechmann A, Flotats-Bastardas M, Schreiber G, Schara U, Plecko B, Trollmann R, Horber V, Wilichowski E, Baumann M, Klein A, Eisenkölbl A, Köhler C, Stettner GM, Cirak S, Hasselmann O, Kaindl AM, Garbade SF, Johannsen J, Ziegler A; SMArtCARE and Swiss-Reg-NMD study group. Weiß C, et al. Lancet Reg Health Eur. 2024 Oct 7;47:101092. doi: 10.1016/j.lanepe.2024.101092. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39434961 Free PMC article.
Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy.
Tscherter A, Steiner L, Broser PJ, Enzmann C, Galiart E, Henzi BC, Jacquier D, Mathis AM, Neuwirth C, Ramelli GP, Ripellino P, Scheidegger O, Schreiner B, Schwarz EI, Stettner GM, Klein A; Swiss-Reg-NMD Group. Tscherter A, et al. Among authors: jacquier d. Clin Neurol Neurosurg. 2025 Aug;255:108983. doi: 10.1016/j.clineuro.2025.108983. Epub 2025 May 26. Clin Neurol Neurosurg. 2025. PMID: 40451126 Free article.
Molecular aspects of insulin therapy in critically ill patients.
Andreelli F, Jacquier D, Troy S. Andreelli F, et al. Among authors: jacquier d. Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):124-30. doi: 10.1097/01.mco.0000214571.97933.0a. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16477177 Review.
Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland.
Tscherter A, Rüsch CT, Baumann D, Enzmann C, Hasselmann O, Jacquier D, Jung HH, Kruijshaar ME, Kuehni CE, Neuwirth C, Stettner GM, Klein A; Swiss-Reg-NMD group. Tscherter A, et al. Among authors: jacquier d. Neuromuscul Disord. 2022 May;32(5):399-409. doi: 10.1016/j.nmd.2022.02.001. Epub 2022 Feb 9. Neuromuscul Disord. 2022. PMID: 35337708 Free article.
17 results